Exploring the views and experiences of women with diabetes in pregnancy in Australia who have been advised to express breast milk antenatally, and implications for clinical practice

Background: The Diabetes and Antenatal Milk Expressing (DAME) randomised controlled trial (RCT) was conducted in 2011 –2015, at six sites in Melbourne, Australia to explore the effect of advising women with diabetes in pregnancy to express breast milk from 36 weeks gestation. The DAME study found no evidence of harm, and that infants whose mothers were randomised to express in pregnancy were more likely to be exc lusively breast milk fed during the hospital stay. The total median amount of breast milk women expressed antenatally was 5mLs and mean number of times of expressing was 22.
Source: Women and Birth - Category: Midwifery Authors: Tags: O72 Source Type: research